ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
35.62
0.96%
US Tech 100
18,064.80
0.02%
S&P 500
5,277.51
0.80%
US Dollar vs CAD
1.36331
-0.14%
Bitcoin
67,671.00
-0.08%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. AMEX
  6. Pro-Pharmaceuticals, (PRW)

  7. Pro-Pharmaceuticals, (PRW) News

PRW

Pro (PRW)

Pro-Pharmaceuticals,
Date:
Sort by:
 Showing the most relevant articles for your search:AMEX:PRW
DateTimeSourceHeadlineSymbolCompany
01/05/20094:00PMEdgar (US Regulatory)Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
12/31/20086:00AMBusiness WirePro-Pharmaceuticals Provides Year-End UpdateAMEX:PRWPro-Pharmaceuticals,
11/20/20086:00AMEdgar (US Regulatory)Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
11/20/20086:00AMBusiness WirePro-Pharmaceuticals Files Registration Statement for Rights Offering to Its ShareholdersAMEX:PRWPro-Pharmaceuticals,
11/19/20084:23PMEdgar (US Regulatory)Securities Registration Statement (S-1)AMEX:PRWPro-Pharmaceuticals,
11/14/20086:00AMBusiness WirePro-Pharmaceuticals to Commence Rights Offering to ShareholdersAMEX:PRWPro-Pharmaceuticals,
11/13/20083:17PMEdgar (US Regulatory)Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
11/13/20083:15PMBusiness WirePro-Pharmaceuticals Receives Delisting Notice from NYSE Alternext USAMEX:PRWPro-Pharmaceuticals,
11/07/20086:31AMEdgar (US Regulatory)Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
11/07/20086:30AMBusiness WirePro-Pharmaceuticals Reports Third Quarter ResultsAMEX:PRWPro-Pharmaceuticals,
11/07/20086:17AMEdgar (US Regulatory)Quarterly Report (10-Q)AMEX:PRWPro-Pharmaceuticals,
11/06/20086:00AMBusiness WirePro-Pharmaceuticals to Present Corporate Update at the Rodman & Renshaw Annual Global Investment ConferenceAMEX:PRWPro-Pharmaceuticals,
10/06/20086:00AMBusiness WirePro-Pharmaceuticals' Pre-NDA Meeting Scheduled with FDAAMEX:PRWPro-Pharmaceuticals,
09/23/200810:27AMEdgar (US Regulatory)Pro Pharmaceuticals Inc - Statement of Changes in Beneficial Ownership (4)AMEX:PRWPro-Pharmaceuticals,
09/18/20086:00AMBusiness WirePro-Pharmaceuticals' Management Outlines Strategic InitiativesAMEX:PRWPro-Pharmaceuticals,
08/28/20086:00AMBusiness WireFDA Grants IND for Pro-Pharmaceuticals' DAVANAT(R) to Treat Breast Cancer PatientAMEX:PRWPro-Pharmaceuticals,
08/08/20086:10AMEdgar (US Regulatory)Pro Pharmaceuticals Inc - Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
08/08/20086:05AMBusiness WirePro-Pharmaceuticals Reports Second Quarter ResultsAMEX:PRWPro-Pharmaceuticals,
08/08/20085:55AMEdgar (US Regulatory)Pro Pharmaceuticals Inc - Quarterly Report (10-Q)AMEX:PRWPro-Pharmaceuticals,
08/06/20086:00AMBusiness WirePro-Pharmaceuticals Granted Pre-IND Meeting for Anti-Hypoxia DrugAMEX:PRWPro-Pharmaceuticals,
08/04/20086:00AMBusiness WireAmex Accepts Pro-Pharmaceuticals Compliance PlanAMEX:PRWPro-Pharmaceuticals,
07/15/20086:00AMBusiness WirePro-Pharmaceuticals Has Requested a Pre-IND Meeting with the U.S. Food and Drug AdministrationAMEX:PRWPro-Pharmaceuticals,
07/11/20086:00AMBusiness WirePro-Pharmaceuticals' Senior Executives to Be Featured on PBS' "Wealth & Wisdom"AMEX:PRWPro-Pharmaceuticals,
07/10/20086:00AMBusiness WirePro-Pharmaceuticals Appoints Noted Pioneer in Liver Diseases, Scott L. Friedman, M.D., to Scientific Advisory BoardAMEX:PRWPro-Pharmaceuticals,
07/09/20086:00AMBusiness WirePro-Pharmaceuticals and Sanghyon Chemical Ink Historic Agency AgreementAMEX:PRWPro-Pharmaceuticals,
06/25/20086:00AMBusiness WirePro-Pharmaceuticals' Executives Contribute to Definitive Book on GalectinsAMEX:PRWPro-Pharmaceuticals,
06/20/20088:20AMEdgar (US Regulatory)Pro Pharmaceuticals Inc - Prospectus filed pursuant to Rule 424(b)(3) (424B3)AMEX:PRWPro-Pharmaceuticals,
06/20/20085:00AMEdgar (US Regulatory)Pro Pharmaceuticals Inc - Notice of Effectiveness (EFFECT)AMEX:PRWPro-Pharmaceuticals,
06/10/20086:02AMEdgar (US Regulatory)Pro Pharmaceuticals Inc - Withdrawal of Registration Statement (RW)AMEX:PRWPro-Pharmaceuticals,
06/02/20083:32PMEdgar (US Regulatory)Pro Pharmaceuticals Inc - Current report filing (8-K)AMEX:PRWPro-Pharmaceuticals,
 Showing the most relevant articles for your search:AMEX:PRW

Your Recent History

USOTC
PHIL
PHI (PK)
NASDAQ
DJT
Trump Media and Technology
NASDAQ
COOP
Mr Cooper
USOTC
RNVA
Rennova Health (PK)
USOTC
FNMA
Fannie Mae (QB)
USOTC
RDGL
Vivos (QB)
USOTC
NSAV
Net Savings Link (PK)
NASDAQ
LWLG
Lightwave Logic
NASDAQ
AVXL
Anavex Life Sciences
USOTC
KBLB
Kraig Biocraft Laborator... (QB)
USOTC
BIEL
Bioelectronics (PK)
NYSE
AMC
AMC Entertainment
USOTC
DBMM
Digital Brand Media and ... (PK)
NASDAQ
AMRN
Amarin
USOTC
TPTW
TPT Global Tech (PK)
NASDAQ
NB
NioCorp Developments
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved